Author Archives: Warren Woessner

D. Mass Court Extends Myriad to Peptide Panels

In a great leap backwards for patenting life sciences, Magistrate Judge Cabell invalidated claims in a number of patents licensed to Oxford Immunotec that are directed to e.g., “A kit for diagnosing infection in a human host by, or exposure … Continue reading

Posted in Patent Eligible Subject Matter | Leave a comment

Apotex v Wyeth Explores Structural Obviousness

Lately, I’ve been feeling that the only case law engaging enough to write about has involved S. 101 issues, so it was a welcome break to comment on some classic principles of organic chemistry. Apotex filed an IPR petition that … Continue reading

Posted in Obviousness | Leave a comment

Arendi S.A.R.L. v. Apple, Inc. – Defining “Common Sense”

For some time, I have wanted to do a post on this recent Fed. Cir. decision (Appeal No. 2015-2073 (Fed. Cir. , August 10,  2016),) in which the Fed. Cir. panel of Judges Moore, Linn and O’Malley (writing) reversed a … Continue reading

Posted in Infringement | 1 Comment

BIO IP & Diagnostics Symposium Guest Post

A guest post from Patent Docs. The Biotechnology Innovation Organization (BIO) will be holding its fourth annual IP & Diagnostics Symposium from 8:15 am to 2:30 pm on September 29, 2016 at the Hilton Alexandria Old Town Hotel in Alexandria, … Continue reading

Posted in BIO, CLE | Leave a comment